Vancomycin: A 50-year reassessment

被引：190

作者：

Moellering, RC ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷

关键词：

D O I：

10.1086/491708

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S3 / S4

页数：2

共 10 条

[1]

[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565

[2]

BRUMMETT RE, 1981, REV INFECT DIS, V3, pS216

[3] RETROSPECTIVE STUDY OF THE TOXICITY OF PREPARATIONS OF VANCOMYCIN FROM 1974 TO 1981 [J].

FARBER, BF ;

MOELLERING, RC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) :138-141

[4] Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001 [J].

Fridkin, SK ;

Hageman, J ;

McDougal, LK ;

Mohammed, J ;

Jarvis, WR ;

Perl, TM ;

Tenover, FC .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (04) :429-439

[5]

GRIFFITH RS, 1981, REV INFECT DIS, V3, pS200

[6] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].

Hiramatsu, K ;

Hanaki, H ;

Ino, T ;

Yabuta, K ;

Oguri, T ;

Tenover, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136

[7] PLASMID-MEDIATED RESISTANCE TO VANCOMYCIN AND TEICOPLANIN IN ENTEROCOCCUS-FAECIUM [J].

LECLERCQ, R ;

DERLOT, E ;

DUVAL, J ;

COURVALIN, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) :157-161

[8] VANCOMYCIN THERAPY IN PATIENTS WITH IMPAIRED RENAL-FUNCTION - A NOMOGRAM FOR DOSAGE [J].

MOELLERING, RC ;

KROGSTAD, DJ ;

GREENBLATT, DJ .

ANNALS OF INTERNAL MEDICINE, 1981, 94 (03) :343-346

[9] Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia [J].

Sakoulas, G ;

Moise-Broder, PA ;

Schentag, J ;

Forrest, A ;

Moellering, RC ;

Eliopoulos, GM .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) :2398-2402

[10]

1981, REV INFECT DIS, V3, pS190

← 1 →